Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-006904

Director acquired 676,072 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trinad Capital Master Fund Ltd. Director 2008-02-05 Grant or award +676,072 2,178,170 D
Loading xslF345X02/v102465_ex.xml…